{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:45:25Z","timestamp":1772808325509,"version":"3.50.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":5026,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1097\/igc.0b013e31821283c3","type":"journal-article","created":{"date-parts":[[2011,3,16]],"date-time":"2011-03-16T07:19:04Z","timestamp":1300259944000},"page":"625-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer"],"prefix":"10.1016","volume":"21","author":[{"given":"Mustafa Abdel Hafiz","family":"El Sherbini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha Mohamed","family":"Sallam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emtiaz Abdel Kawy","family":"Shaban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amr Hassan","family":"El-Shalakany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31821283c3_bb0005","first-page":"CR84","article-title":"Tumor marker CA-125 as an evaluator and response indicator in ovarian cancer: its quantitative correlation with tumor volume","volume":"11","author":"Kumar","year":"2005","journal-title":"Med Sci Monit."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0010","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/172460089801300402","article-title":"CA125: the past and the future","volume":"13","author":"Bast","year":"1998","journal-title":"IntJ Biol Markers."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0015","first-page":"389","article-title":"Total serum sialic acid concentration as a supporting marker of malignancy in ovarian neoplasia","volume":"20","author":"Berbe\u0107","year":"1999","journal-title":"Eur J Gynaecol Oncol."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0020","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1447-0756.2003.00176.x","article-title":"Preoperative serum inhibin levels in patients with ovarian tumors","volume":"30","author":"El-Shalakany","year":"2004","journal-title":"J Obstet Gynaecol Res."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0025","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.2008.19.2484","article-title":"Development of multimarker assay for early detection of ovarian cancer","volume":"28","author":"Yurkovetsky","year":"2010","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.ygyno.2010.02.005","article-title":"Serum biomarker panels for the discrimination of benign from malignant cases in patients with adnexal mass","volume":"117","author":"Nolen","year":"2010","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0035","first-page":"14","article-title":"Prostate specific antigen\u2014its usefulness in clinical medicine","volume":"25","author":"Diamandis","year":"1999","journal-title":"Trends Endocrinol Metab."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0040","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1158\/1078-0432.CCR-06-2482","article-title":"Primary tumor levels of human tissue kallikreins affect surgical success and survival in ovarian cancer patients","volume":"13","author":"Dorn","year":"2007","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/BF03401646","article-title":"A novel protease homolog differentially expressed in breast and ovarian cancer","volume":"2","author":"Anisowicz","year":"1996","journal-title":"Mol Med."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0050","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0009-9120(00)00182-X","article-title":"Kallikrein 6 (zyme\/protease M\/neurosin): a new serum biomarker of ovarian carcinoma","volume":"33","author":"Diamandis","year":"2000","journal-title":"Clin Biochem."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0009-8981(01)00401-6","article-title":"Human kallikrein 10: a novel tumor marker for ovarian carcinoma?","volume":"306","author":"Luo","year":"2001","journal-title":"Clin Chim Acta."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0060","first-page":"2372","article-title":"Prognostic value of human kallikrein 10 expression in epithelial ovarian carcinoma","volume":"7","author":"Luo","year":"2001","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0065","first-page":"1035","article-title":"Human kallikrein 6 (hK6): a new potential biomarker for diagnosis and prognosis of ovarian carcinoma","volume":"21","author":"Diamandis","year":"2003","journal-title":"Clin Oncol."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0070","first-page":"807","article-title":"The serum concentration of human kallikrein 10 represents a novel biomarker for ovarian cancer diagnosis and prognosis","volume":"63","author":"Luo","year":"2003","journal-title":"Cancer Res."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0075","first-page":"1107","article-title":"KLK6 and KLK13 predict tumor recurrence in epithelial ovarian carcinoma","volume":"101","author":"White","year":"2009","journal-title":"BrJCancer."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0080","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/CBM-2009-0113","article-title":"Human kallikrein related peptidases 6 and 13 in combination with CA125 is a more sensitive test for ovarian cancer than CA125 alone","volume":"5","author":"White","year":"2009","journal-title":"Cancer Biomark."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0085","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0009-9120(00)00145-4","article-title":"Immunofluorometric assay of human kallikrein 6 (zyme\/protease M\/neurosin) and preliminary clinical applications","volume":"33","author":"Diamandis","year":"2000","journal-title":"Clin Biochem."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0090","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/clinchem\/47.2.237","article-title":"Immunofluorometric assay of human kallikrein 10 and its identification in biological fluids and tissues","volume":"47","author":"Luo","year":"2001","journal-title":"Clin Chem."},{"key":"10.1097\/IGC.0b013e31821283c3_bb0095","series-title":"Cancer Management: A Multidisciplinary Approach","first-page":"509","article-title":"Ovarian cancer: epidemiology","author":"Rubin","year":"2005"},{"key":"10.1097\/IGC.0b013e31821283c3_bb0100","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/annonc\/mdl499","article-title":"Pattern and prognostic factors in patients with malignant ascites: a retrospective study","volume":"18","author":"Ayantunde","year":"2007","journal-title":"Ann Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24038507?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24038507?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1097\/IGC.0b013e31821283c3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,14]],"date-time":"2025-02-14T03:31:55Z","timestamp":1739503915000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24038507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1048891X24038507"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31821283c3","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Value of Serum Kallikrein-Related Peptidases 6 and 10 Versus CA125 in Ovarian Cancer","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31821283c3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 by IGCS and ESGO","name":"copyright","label":"Copyright"}]}}